IFNG and neoplasm: As an example, PEGylation of IFNγ increased the half-life 20-fold and was significantly more effective than non-PEGylated IFNγ at preventing growth of a human tumor xenograft in athymic (no T cells) mice.153 This reduction in clearance rate is considered to arise due to the PEG preventing protease-mediated degradation.